|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/445 | |
| A61K 45/06 | |||
| A61K 9/00 | |||
| A61K 9/06 | |||
| A61K 9/08 | |||
| A61P 27/02 | |||
| A61P 27/04 |
| (11) | Patento numeris | 3319639 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16736636.8 |
| Europos patento paraiškos padavimo data | 2016-07-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2016/054073 |
| Data | 2016-07-07 |
| (87) | Numeris | WO 2017/006272 |
| Data | 2017-01-12 |
| (30) | Numeris | Data | Šalis |
| 201562189813 P | 2015-07-08 | US |
| (72) |
KRAUSS, Achim Hans-Peter, US
|
| (73) |
Axerovision, Inc.,
5857 Owens Ave., Suite 300, Carlsbad, CA 92008,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING AN INTEGRIN ALPHA4 ANTAGONIST FOR USE IN TREATING OCULAR INFLAMMATORY CONDITIONS |
| PHARMACEUTICAL COMPOSITIONS COMPRISING AN INTEGRIN ALPHA4 ANTAGONIST FOR USE IN TREATING OCULAR INFLAMMATORY CONDITIONS |